Literature DB >> 21999396

Anti-inflammatory effects of active constituents extracted from Chinese medicinal herbs against Propionibacterium acnes.

Shiyu Fu1, Changlei Sun, Xinyi Tao, Yuhong Ren.   

Abstract

Interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-α) from keratinocyte play important roles in initiating the inflammatory process of acne. They are used as major elements to evaluate the anti-inflammatory activity of drugs. In this study, various active constituents extracted from Chinese medicinal herbs were tested for their anti-inflammatory effects against P. acnes using ELISA. Among the constituents, matrine, baicalin, ursolic acid, sodium danshensu, magnolol, honokiol, hesperidin and andrographolide significantly reduced IL-8 and TNF-α by human HaCaT keratinocyte cells pretreated with heat-killed P. acnes. Excepting hesperidin, these active constituents presented dose-dependent inhibitory effects. Our studies showed that all of them exhibited low cytotoxicity at 5 µg mL⁻¹ in tested cell lines, and even at 50 µg mL⁻¹, in the cases of matrine, baicalin, ursolic acid and sodium danshensu. Based on the obtained results, it can be suggested that these active constituents are potential acne-mitigating candidates for cosmetic applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999396     DOI: 10.1080/14786419.2011.608675

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  9 in total

1.  Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells.

Authors:  Yoshitaka Hosokawa; Ikuko Hosokawa; Kazumi Ozaki; Takashi Matsuo
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

Review 2.  New perspectives on antiacne plant drugs: contribution to modern therapeutics.

Authors:  Priyam Sinha; Shruti Srivastava; Nidhi Mishra; Narayan Prasad Yadav
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

3.  Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells.

Authors:  Lingdi Ma; Zhenyu Xu; Jian Wang; Zhichao Zhu; Guibin Lin; Lijia Jiang; Xuzhang Lu; Chang Zou
Journal:  Oncotarget       Date:  2017-11-10

4.  Using Coexpression Protein Interaction Network Analysis to Identify Mechanisms of Danshensu Affecting Patients with Coronary Heart Disease.

Authors:  Mengqi Huo; Zhixin Wang; Dongxue Wu; Yanling Zhang; Yanjiang Qiao
Journal:  Int J Mol Sci       Date:  2017-06-19       Impact factor: 5.923

5.  Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway.

Authors:  Jianyou Gu; Yu Zhang; Xiao Wang; Jingjing Xiang; Shu Deng; Dijiong Wu; Junfa Chen; Lihong Yu; Yan Zhou; Yaokun Wang; Jianping Shen
Journal:  BMC Complement Med Ther       Date:  2020-07-08

Review 6.  Benefits of Hesperidin for Cutaneous Functions.

Authors:  Mao-Qiang Man; Bin Yang; Peter M Elias
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-02       Impact factor: 2.629

7.  Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives.

Authors:  Sumit Kumar Dey; Dipayan Bose; Abhijit Hazra; Subhendu Naskar; Abhishek Nandy; Rudra Narayan Munda; Subhadip Das; Nabanita Chatterjee; Nirup Bikash Mondal; Sukdeb Banerjee; Krishna Das Saha
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

8.  Matrine effectively inhibits the proliferation of breast cancer cells through a mechanism related to the NF-κB signaling pathway.

Authors:  Hongmin Shao; Baowen Yang; Rongrong Hu; Yingying Wang
Journal:  Oncol Lett       Date:  2013-06-14       Impact factor: 2.967

9.  Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57.

Authors:  Mengjie Wang; Qi Dong; Hua Wang; Yaqing He; Ying Chen; Hong Zhang; Rong Wu; Xinchun Chen; Boping Zhou; Jason He; Hsiang-Fu Kung; Canhua Huang; Yuquan Wei; Jian-dong Huang; Hongxi Xu; Ming-Liang He
Journal:  Oncotarget       Date:  2016-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.